Gene therapy takes on deadly brain cancer
Disease control
Ongoing
This trial tests a new gene therapy called Temferon for glioblastoma, a fast-growing brain cancer. It involves taking a patient's own blood stem cells, modifying them to produce an immune-boosting protein, and giving them back after chemotherapy. The study includes up to 27 patie…
Phase: PHASE1, PHASE2 • Sponsor: Genenta Science • Aim: Disease control
Last updated May 01, 2026 15:57 UTC